Copyright
©The Author(s) 2019.
World J Clin Cases. Sep 6, 2019; 7(17): 2413-2419
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2413
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2413
Table 2 Grading system of well-differentiated neuroendocrine tumors according to the 2017 World Health Organization classification
| Neuroendocrine tumor | Mitotic index | Ki67 proliferation index |
| Neuroendocrine tumor (G1) (well differentiated) | < 2 | < 3% |
| Neuroendocrine tumor (G2) (well differentiated) | 2-20 | 3%-20% |
| Neuroendocrine tumor (G3) (well | > 20 | > 20% |
- Citation: Algashaamy K, Garcia-Buitrago M. Multifocal G1-G2 gastric neuroendocrine tumors: Differentiating between Type I, II and III, a clinicopathologic review. World J Clin Cases 2019; 7(17): 2413-2419
- URL: https://www.wjgnet.com/2307-8960/full/v7/i17/2413.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i17.2413